arrow
M

Muktha S. Natrajan

Centers for Disease Control and Prevention
H指数:16
被引数:1,238

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A Phase 1, Double-Blinded, Placebo-Controlled Clinical Trial to Evaluate the Safety and Immunogenicity of HEV-239 (Hecolin) Vaccine in Healthy US Adults
2024-03-276
PRE
The Vacc-SeqQC project: Benchmarking RNA-Seq for clinical vaccine studies (vol 13, 1093242, 2023)
2023-02-230
OAAI
Dose-Response of a Norovirus GII.2 Controlled Human Challenge Model Inoculum
2022-02-086
OA
Immunologic mechanisms of seasonal influenza vaccination administered by microneedle patch from a randomized phase I trial
2021-07-1418
OAAI
Transcriptomic and Metabolic Responses to a Live-Attenuated Francisella tularensis Vaccine

对tularensis Francisella tularensis减毒活疫苗的转录组和代谢反应

2020-07-2413
OAAI
Alterations in the Human Plasma Lipidome in Response to Tularemia Vaccination
2020-07-249
OAAI
Squalene emulsion-based vaccine adjuvants stimulate CD8 T cell, but not antibody responses, through a RIPK3-dependent pathway

基于角鲨烯乳剂的疫苗佐剂通过RIPK3-dependent途径刺激CD8 T细胞,但不刺激抗体反应

2020-06-0966
OA
Clinical, Virologic, and Immunologic Characteristics of Zika Virus Infection in a Cohort of US Patients: Prolonged RNA Detection in Whole Blood
2018-12-1927
OAAI
Innate, T-, and B-Cell Responses in Acute Human Zika Patients
2017-08-1758
OAAI